United States · FDA National Drug Code directory

bacitracin zinc, neomycin sulfate and polymyxin b sulfate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
67777-217_38cfd292-4dae-2caf-e063-6394a90a0527
Product NDC
67777-217
Form
OINTMENT
Composition / generic term
bacitracin zinc, neomycin sulfate and polymyxin b sulfate
Labeler
Dynarex Corporation
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20091201
Source listing expiry
20261231

Source-listed ingredients

  • BACITRACIN ZINC — 400 [iU]/g
  • NEOMYCIN SULFATE — 5 mg/g
  • POLYMYXIN B SULFATE — 5000 [iU]/g

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 BOX in 1 CASE (67777-217-08) / 10 PACKET in 1 BOX (67777-217-04) / .5 g in 1 PACKET · 67777-217-08
  • 72 BOX in 1 CASE (67777-217-11) / 1 TUBE in 1 BOX (67777-217-10) / 28.35 g in 1 TUBE (67777-217-01) · 67777-217-11
  • 72 BOX in 1 CASE (67777-217-13) / 1 TUBE in 1 BOX (67777-217-12) / 14.17 g in 1 TUBE (67777-217-02) · 67777-217-13
  • 12 BOX in 1 CASE (67777-217-15) / 144 PACKET in 1 BOX (67777-217-14) / .9 g in 1 PACKET (67777-217-07) · 67777-217-15
  • 12 BOX in 1 CASE (67777-217-17) / 144 PACKET in 1 BOX (67777-217-16) / .5 g in 1 PACKET (67777-217-05) · 67777-217-17

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →